Kiho Lee - Sk Biopharmaceutica VP CTO
| 326030 Stock | 100,900 5,500 5.77% |
CTO
Kiho Lee is VP CTO of Sk Biopharmaceuticals Co
| Phone | 82 31 8093 0114 |
| Web | https://www.skbp.com |
Sk Biopharmaceutica Management Efficiency
The company has return on total asset (ROA) of 0.0475 % which means that it generated a profit of $0.0475 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1245) %, meaning that it generated substantial loss on money invested by shareholders. Sk Biopharmaceutica's management efficiency ratios could be used to measure how well Sk Biopharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities. Sk Biopharmaceuticals Co (326030) is traded on Korea Stock Exchange in Korea and employs 10 people.Management Performance
| Return On Equity | -0.12 | |||
| Return On Asset | 0.0475 |
Sk Biopharmaceuticals Leadership Team
Elected by the shareholders, the Sk Biopharmaceutica's board of directors comprises two types of representatives: Sk Biopharmaceutica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 326030. The board's role is to monitor Sk Biopharmaceutica's management team and ensure that shareholders' interests are well served. Sk Biopharmaceutica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sk Biopharmaceutica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Wanho Nam, VP HR | ||
| Jiyoung Jung, VP CFO | ||
| Sungwan Hwang, VP Innovation | ||
| Dong Lee, CEO Chairman | ||
| Jeong Cho, CEO Pres | ||
| Jooyup Chae, VP Counsel | ||
| HyungRae Cho, F Exec | ||
| Jungshin Park, VP Unit | ||
| Kiho Lee, VP CTO | ||
| Changho CFA, VP Officer |
326030 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sk Biopharmaceutica a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.12 | |||
| Return On Asset | 0.0475 | |||
| Profit Margin | (0.12) % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 5.87 T | |||
| Shares Outstanding | 78.31 M | |||
| Shares Owned By Insiders | 64.28 % | |||
| Shares Owned By Institutions | 5.26 % | |||
| Price To Book | 15.89 X | |||
| Price To Sales | 13.94 X |
Pair Trading with Sk Biopharmaceutica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sk Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.Moving together with 326030 Stock
Moving against 326030 Stock
The ability to find closely correlated positions to Sk Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sk Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sk Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sk Biopharmaceuticals Co to buy it.
The correlation of Sk Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sk Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sk Biopharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sk Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in 326030 Stock
Sk Biopharmaceutica financial ratios help investors to determine whether 326030 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 326030 with respect to the benefits of owning Sk Biopharmaceutica security.